Evidence map›Paper›PMID 41786996›Full record

ArticleScientific reports2026

Hallucination-aware learning and latency optimization transformer (HALL-OPT) for real-time edge intelligence.

Danah Algawiaz

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Danah AlgawiazDepartment of Information Systems, College of Computing and Information Technology, Shaqra University, Shaqra, Saudi Arabia. dalgawiaz@su.edu.sa.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transformer architectures and large language models remain competitive across a broad range of AI tasks, making them challenging to deploy in resource-constrained edge computing environments due to high resource demands and the generation of erroneous or fake outputs (hallucinations). In this paper, a single scheme, HALL-OPT, is proposed to address both latency detection and reduction in hallucination for real-time edge intelligence. The paper presents three main elements of the framework, namely, (1) a dual-stream hallucination detector that analyses internal attention behaviour, (2) an adaptive token-pruning system, which decodes and extracts the necessary context at minimal computation, and (3) a lightweight edge-optimized transformer obtained by knowledge distillation. On SQuAD 2.0 and CNN/DailyMail, HALL-OPT detects hallucinations accurately at 94.3% and achieves a 67.8% reduction in inference latency with only a 2.1% decrease in accuracy compared to the BERT-base model. The system (when deployed on edge hardware) provides sub-50 ms response times while consuming 43% less energy. It is appropriate for real-time applications in industrial IoT, autonomous systems, healthcare monitoring, and other applications where low latency is critical. Existing transformer optimisation and hallucination mitigation approaches treat reliability and Efficiency as separate objectives, limiting their applicability in real-time edge environments. HALL-OPT uniquely integrates hallucination-aware attention, adaptive pruning, and edge-oriented optimisation into a single unified framework, enabling simultaneous reductions in hallucination, latency, and energy consumption. This integrated design distinguishes HALL-OPT from prior work that optimises accuracy or Efficiency in isolation.

Indexed as

Attention mechanismEdge computingHallucination detectionKnowledge distillationLatency reductionReal-time inferenceTransformer optimisation

Identifiers

PMID41786996
PMCPMC13079745

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.